Login
Omega Therapeutics, Inc. logo

Omega Therapeutics, Inc.

omegatherapeutics.com

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. The company is headquartered in Cambridge, Massachusetts and currently employs 93 full-time employees. The firm has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code. The firm remains in possession of its assets and continues to operate its business as a debtor in possession.

Financial snapshot data is not available right now.

Stock Price

Loading...
Market Cap: $170 Thousand

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support